Cargando…

Doxycycline-induced ulceration mimicking esophageal cancer

INTRODUCTION: Doxycycline-induced esophageal ulcer patients are mostly young persons with no history of esophageal dysfunction. Heartburn, midsternal pain and dysphagia are the most common symptoms. It has generally a benign course. The present case is the first report of doxycycline-induced extensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahan, Veysel, Sayrak, Hakan, Bayar, Nevzat, Erer, Burak, Tahan, Gulgun, Dane, Faysal
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553052/
https://www.ncbi.nlm.nih.gov/pubmed/18778470
http://dx.doi.org/10.1186/1757-1626-1-144
_version_ 1782159472782737408
author Tahan, Veysel
Sayrak, Hakan
Bayar, Nevzat
Erer, Burak
Tahan, Gulgun
Dane, Faysal
author_facet Tahan, Veysel
Sayrak, Hakan
Bayar, Nevzat
Erer, Burak
Tahan, Gulgun
Dane, Faysal
author_sort Tahan, Veysel
collection PubMed
description INTRODUCTION: Doxycycline-induced esophageal ulcer patients are mostly young persons with no history of esophageal dysfunction. Heartburn, midsternal pain and dysphagia are the most common symptoms. It has generally a benign course. The present case is the first report of doxycycline-induced extensive ulcerations, mimicking esophageal cancer in two esophageal segments alongside, in the literature. CASE PRESENTATION: This report describes a 16-year-old Caucasian girl who, while taking doxycycline capsules100 mg twice a day for acne vulgaris for 3 months, developed these symptoms. An upper endoscopy revealed multiple circumferential deep ulcerations surrounding fragile, irregular, hyperemic and hypertrophic mucosa at the level of the mid-esophagus and concomitantly in the lower esophageal sphincter. The lesions were biopsied to exclude esophageal carcinoma because of the suspicious appearance in the endoscopic examination. The histopathological examination, haematoxylin and eosin stained sections showed ulceration with a mixed inflammatory infiltrate. Doxycycline was discontinued and she was given sucralfate 1 g qid and omeprazole 20 mg bid orally. All symptoms of the patient were resolved on the third day of the treatment. After 4 weeks of the therapy, an upper endoscopic control examination demonstrated normal findings. CONCLUSION: The present case has been an uncommon presentation of doxycycline-induced extensive ulcerations, mimicking esophageal cancer in two esophageal segments, concomitantly. Even the lesions were biopsied to exclude esophageal carcinoma. A modification on the behavior of taking drugs can prevent these unpleasant complications.
format Text
id pubmed-2553052
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25530522008-09-25 Doxycycline-induced ulceration mimicking esophageal cancer Tahan, Veysel Sayrak, Hakan Bayar, Nevzat Erer, Burak Tahan, Gulgun Dane, Faysal Cases J Case Report INTRODUCTION: Doxycycline-induced esophageal ulcer patients are mostly young persons with no history of esophageal dysfunction. Heartburn, midsternal pain and dysphagia are the most common symptoms. It has generally a benign course. The present case is the first report of doxycycline-induced extensive ulcerations, mimicking esophageal cancer in two esophageal segments alongside, in the literature. CASE PRESENTATION: This report describes a 16-year-old Caucasian girl who, while taking doxycycline capsules100 mg twice a day for acne vulgaris for 3 months, developed these symptoms. An upper endoscopy revealed multiple circumferential deep ulcerations surrounding fragile, irregular, hyperemic and hypertrophic mucosa at the level of the mid-esophagus and concomitantly in the lower esophageal sphincter. The lesions were biopsied to exclude esophageal carcinoma because of the suspicious appearance in the endoscopic examination. The histopathological examination, haematoxylin and eosin stained sections showed ulceration with a mixed inflammatory infiltrate. Doxycycline was discontinued and she was given sucralfate 1 g qid and omeprazole 20 mg bid orally. All symptoms of the patient were resolved on the third day of the treatment. After 4 weeks of the therapy, an upper endoscopic control examination demonstrated normal findings. CONCLUSION: The present case has been an uncommon presentation of doxycycline-induced extensive ulcerations, mimicking esophageal cancer in two esophageal segments, concomitantly. Even the lesions were biopsied to exclude esophageal carcinoma. A modification on the behavior of taking drugs can prevent these unpleasant complications. BioMed Central 2008-09-08 /pmc/articles/PMC2553052/ /pubmed/18778470 http://dx.doi.org/10.1186/1757-1626-1-144 Text en Copyright © 2008 Tahan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Tahan, Veysel
Sayrak, Hakan
Bayar, Nevzat
Erer, Burak
Tahan, Gulgun
Dane, Faysal
Doxycycline-induced ulceration mimicking esophageal cancer
title Doxycycline-induced ulceration mimicking esophageal cancer
title_full Doxycycline-induced ulceration mimicking esophageal cancer
title_fullStr Doxycycline-induced ulceration mimicking esophageal cancer
title_full_unstemmed Doxycycline-induced ulceration mimicking esophageal cancer
title_short Doxycycline-induced ulceration mimicking esophageal cancer
title_sort doxycycline-induced ulceration mimicking esophageal cancer
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553052/
https://www.ncbi.nlm.nih.gov/pubmed/18778470
http://dx.doi.org/10.1186/1757-1626-1-144
work_keys_str_mv AT tahanveysel doxycyclineinducedulcerationmimickingesophagealcancer
AT sayrakhakan doxycyclineinducedulcerationmimickingesophagealcancer
AT bayarnevzat doxycyclineinducedulcerationmimickingesophagealcancer
AT ererburak doxycyclineinducedulcerationmimickingesophagealcancer
AT tahangulgun doxycyclineinducedulcerationmimickingesophagealcancer
AT danefaysal doxycyclineinducedulcerationmimickingesophagealcancer